Long-term (LT) Exposure to low-dose prednisone given with or without abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC) patients

被引：0
|
作者：
Ryan, Charles J. [1 ]
Chi, Kim N. [2 ]
de Bono, Johann S. [3 ,4 ]
Fizazi, Karim [5 ]
Gomella, Leonard G. [6 ,7 ]
Miller, Kurt [10 ]
Rathkopf, Dana E. [8 ,9 ,11 ]
Scher, Howard I. [6 ,7 ]
Shore, Neal D. [10 ]
De Porre, Peter [8 ,9 ,11 ]
Londhe, Anil [8 ,9 ,11 ]
McGowan, Tracy [12 ]
Pelhivanov, Nonko [8 ,9 ,11 ]
Charnas, Robert [8 ,9 ,11 ]
Todd, Mary B. [13 ]
Montgomery, Bruce [14 ]
机构：
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[2] BC Canc Agcy, Vancouver, BC, Canada
[3] Inst Canc Res, London, England
[4] Univ Paris 11, Inst Gustave Roussy, Paris, France
[5] Univ Paris 11, Inst Gustave Roussy, Paris, France
[6] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA USA
[7] Charite Univ Med Berlin, Berlin, Germany
[8] Mem Sloan Kettering Canc Ctr, New York, NY USA
[9] Weill Cornell Med Coll, New York, NY USA
[10] Atlantic Urol Clin, Carolina Urol Res Ctr, Panama City, Panama
[11] Janssen Res & Dev, London, England
[12] Janssen Sci Affairs, London, England
[13] Janssen Global Serv, Titusville, NJ USA
[14] Univ Washington, Seattle, WA 98195 USA
来源：
BJU INTERNATIONAL | 2015年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
118
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [31] Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
    Chi, Kim N.
    Rathkopf, Dana
    Smith, Matthew R.
    Efstathiou, Eleni
    Attard, Gerhardt
    Olmos, David
    Lee, Ji Youl
    Small, Eric J.
    Gomes, Andrea J. Pereira De Santana
    Roubaud, Guilhem
    Saad, Marniza
    Zurawski, Bogdan
    Sakalo, Valerii
    Mason, Gary E.
    Francis, Peter
    Ms, George Wang
    Wu, Daphne
    Diorio, Brooke
    Lopez-Gitlitz, Angela
    Sandhu, Shahneen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (18) : 3339 - +
  • [32] Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors
    Verzoni, Elena
    Grassi, Paolo
    Ratta, Raffaele
    Niger, Monica
    De Braud, Filippo
    Valdagni, Riccardo
    Procopio, Giuseppe
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2016, 8 (05) : 323 - 330
  • [33] Enzalutamide (ENZA) in combination with abiraterone acetate (AA) in bone metastatic castration resistant prostate cancer (mCRPC)
    Efstathiou, Eleni
    Titus, Mark Anton
    Wen, Sijin
    SanMiguel, Aileen
    Hoang, Anh
    De Haas-Amatsaleh, Angela
    Perabo, Frank
    De Phung
    Troncoso, Patricia
    Ouatas, Taoufik
    Logothetis, Christopher
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Erratum to Abiraterone acetate: in metastatic castration-resistant prostate cancer
    L. P. H. Yang
    [J]. Drugs, 2012, 72 (2) : 192 - 192
  • [35] Abiraterone Acetate (Zytiga) for Metastatic Castration-Resistant Prostate Cancer
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1370): : 63 - 64
  • [36] Safety and clinical outcomes of abiraterone acetate (aa) after docetaxel (doc) in octogenarians with metastatic castration-resistant prostate cancer (mcrpc)
    Caffo, O.
    Maines, F.
    De Giorgi, U.
    Fratino, L.
    Lo Re, G.
    Zagonel, V.
    D'Angelo, A.
    Donini, M.
    Verderame, F.
    Ratta, R.
    Procopio, G.
    Campadelli, E.
    Massari, F.
    Gasparro, D.
    Ermacora, P.
    Messina, C.
    Giordano, M.
    Alesini, D.
    Conteduca, V.
    Veccia, A.
    Galligioni, E.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 61 - 61
  • [37] An exploratory analysis of efficacy and safety of abiraterone acetate (AA) in black patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) without prior chemotherapy (ctx)
    Efstathiou, Eleni
    Deshpande, Hari
    George, Daniel
    Joshua, Anthony M.
    Taplin, Mary-Ellen
    Griffin, Thomas W.
    Londhe, Anil
    Todd, Mary
    Molina, Arturo
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [38] Effects of 6 months of abiraterone acetate (AA) on muscle and adipose mass in men with metastatic castration-resistant prostate cancer (mCRPC)
    Brondfield, Samuel Craig
    Weinberg, Vivian K.
    Koepfgen, Kathryn M.
    Molina, Arturo
    Ryan, Charles J.
    Small, Eric Jay
    Harzstark, Andrea Lynne
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Germline variant in SLCO2B1 and response to abiraterone acetate plus prednisone (AA) in men with metastatic castration-resistant prostate cancer (mCRPC).
    Hahn, Andrew W.
    Patel, Darshan
    Gill, David Michael
    Froerer, Camryn
    Nussensveig, Roberto
    Poole, Austin
    Hale, Peter
    Farnham, James M.
    Maughan, Benjamin Louis
    Cannon-Albright, Lisa A.
    Agarwal, Neeraj
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [40] Effects of 6 months of abiraterone acetate (AA) on muscle and adipose mass in men with metastatic castration-resistant prostate cancer (mCRPC)
    Brondfield, Samuel Craig
    Weinberg, Vivian K.
    Koepfgen, Kathryn M.
    Molina, Arturo
    Ryan, Charles J.
    Small, Eric Jay
    Harzstark, Andrea Lynne
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
12345